BlackRock Portfolio holdings
AUM $5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+14%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$5.23T
AUM Growth
+$486B
(+10%)
Cap. Flow
+$960M
Cap. Flow
% of AUM
0.02%
Top 10 Holdings %
Top 10 Hldgs %
28.22%
Holding
5,601
New
192
Increased
2,077
Reduced
2,507
Closed
189
Top Buys
| 1 |
Capital One
COF
|
+$4.84B |
| 2 |
Amazon
AMZN
|
+$2.06B |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$2.01B |
| 4 |
Apple
AAPL
|
+$1.77B |
| 5 |
Broadcom
AVGO
|
+$1.39B |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$3.51B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.97B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.65B |
| 4 |
Palantir
PLTR
|
+$1.5B |
| 5 |
Texas Instruments
TXN
|
+$1.44B |
Sector Composition
| 1 | Technology | 31.15% |
| 2 | Financials | 13.27% |
| 3 | Consumer Discretionary | 10.11% |
| 4 | Healthcare | 9.81% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Energy Transfer Partners
ET
$60.2B
| $57M | ﹤0.01% |
3,144,179
+2,798,786
| +810% | +$50.7M |
|
2327
Agilon Health
AGL
$460M
| $57M | ﹤0.01% |
24,773,117
+36,459
| +0.1% | +$83.9K |
|
|
GLXY
2328
Galaxy Digital Inc. Class A Common Stock
GLXY
$5.3B
| $56.8M | ﹤0.01% |
+2,595,796
| New | +$56.8M |
|
2329
Gorman-Rupp
GRC
$1.14B
| $56.8M | ﹤0.01% |
1,547,815
-27,801
| -2% | -$1.02M |
|
2330
Hackett Group
HCKT
$570M
| $56.6M | ﹤0.01% |
2,225,196
-202,428
| -8% | -$5.15M |
|
2331
Fidelis Insurance
FIHL
$1.84B
| $56.6M | ﹤0.01% |
3,411,030
+479,495
| +16% | +$7.95M |
|
2332
Fomento Económico Mexicano
FMX
$32.7B
| $56.5M | ﹤0.01% |
548,320
-227,493
| -29% | -$23.4M |
|
2333
York Water
YORW
$439M
| $56.4M | ﹤0.01% |
1,786,098
+158,738
| +10% | +$5.02M |
|
2334
Dole
DOLE
$1.3B
| $56.4M | ﹤0.01% |
4,034,143
-458,210
| -10% | -$6.41M |
|
|
NPKI
2335
NPK International Inc.
NPKI
$907M
| $56.1M | ﹤0.01% |
6,596,711
-327,290
| -5% | -$2.79M |
|
|
BRSP
2336
BrightSpire Capital
BRSP
$755M
| $56M | ﹤0.01% |
11,087,626
-613,299
| -5% | -$3.1M |
|
|
QXO.PRB
2337
QXO, Inc. Depositary Shares, each representing a 1/20th interest in a share of 5.50% Series B Mandatory Convertible Preferred Stock
QXO.PRB
$694M
| $55.8M | ﹤0.01% |
+900,314
| New | +$55.8M |
|
2338
Canadian Natural Resources
CNQ
$66.6B
| $55.6M | ﹤0.01% |
1,772,007
+114,195
| +7% | +$3.59M |
|
|
NAGE
2339
Niagen Bioscience, Inc. Common Stock
NAGE
$772M
| $55.6M | ﹤0.01% |
3,856,324
+239,253
| +7% | +$3.45M |
|
2340
SFL Corp
SFL
$1.06B
| $55.5M | ﹤0.01% |
6,666,794
-467,520
| -7% | -$3.89M |
|
2341
Regenxbio
RGNX
$459M
| $55.5M | ﹤0.01% |
6,759,093
+1,304,573
| +24% | +$10.7M |
|
2342
Integral Ad Science
IAS
$1.39B
| $55.4M | ﹤0.01% |
6,667,605
+663,535
| +11% | +$5.51M |
|
2343
Genco Shipping & Trading
GNK
$783M
| $55.4M | ﹤0.01% |
4,238,226
-233,896
| -5% | -$3.06M |
|
2344
Blend Labs
BLND
$1.1B
| $55.3M | ﹤0.01% |
16,768,360
-1,400,249
| -8% | -$4.62M |
|
2345
Central Garden & Pet
CENT
$2.24B
| $55.3M | ﹤0.01% |
1,571,970
-99,318
| -6% | -$3.49M |
|
2346
Merus
MRUS
$5.15B
| $55.3M | ﹤0.01% |
1,050,942
-640,927
| -38% | -$33.7M |
|
2347
SK Telecom
SKM
$8.4B
| $55.2M | ﹤0.01% |
2,362,650
+911,081
| +63% | +$21.3M |
|
2348
Excelerate Energy
EE
$764M
| $54.9M | ﹤0.01% |
1,873,793
+429,860
| +30% | +$12.6M |
|
2349
Ambev
ABEV
$36.3B
| $54.9M | ﹤0.01% |
22,778,969
+1,962,743
| +9% | +$4.73M |
|
2350
Takeda Pharmaceutical
TAK
$47.6B
| $54.9M | ﹤0.01% |
3,550,877
+920,044
| +35% | +$14.2M |
|